Product image of Glucose/Sodium Chloride Fresenius Kabi (Sodium Chloride, Glucose Monohydrate) supplied by GNH India

Glucose/Sodium Chloride Fresenius Kabi

Active Ingredient:
Sodium Chloride, Glucose Monohydrate
Origin:
EU

Glucose/Sodium Chloride Fresenius Kabi (Sodium Chloride, Glucose Monohydrate)

Glucose/Sodium Chloride Fresenius Kabi is an injectable solution that contains sodium chloride and glucose monohydrate. It is supplied as a sterile intravenous (IV) fluid for infusion, intended for use in clinical settings within the European Union. The product provides both electrolytes and carbohydrate energy to support fluid balance and metabolic needs during medical treatment.

Manufacturer / TM Owner

Fresenius Kabi S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose/Sodium Chloride Fresenius Kabi is used in a variety of clinical situations where fluid, electrolyte, and energy replacement are required.

  • Fluid replacement in patients with dehydration or blood loss
  • Electrolyte replenishment for sodium and chloride deficits
  • Treatment of hypoglycemia when rapid glucose delivery is needed
  • Component of parenteral nutrition regimens
  • Support during surgery or intensive care for maintaining intravascular volume

Side Effects

Adverse reactions to Glucose/Sodium Chloride Fresenius Kabi may vary in frequency and severity.

Common

  • Local irritation at the infusion site
  • Mild nausea or vomiting
  • Transient hyperglycemia
  • Mild electrolyte imbalance (e.g., hypernatremia)
  • Headache
  • Mild fever

Serious

  • Severe hyperglycemia leading to osmotic diuresis
  • Significant electrolyte disturbances (e.g., severe hypernatremia, hyperchloremic acidosis)
  • Anaphylactic or severe allergic reaction
  • Thrombophlebitis or venous thrombosis
  • Fluid overload with pulmonary edema

Precautions & Warnings

When administering Glucose/Sodium Chloride Fresenius Kabi, clinicians should consider several safety factors.

  • Assess patient’s fluid status and electrolyte levels before infusion
  • Monitor blood glucose regularly, especially in diabetic patients
  • Adjust infusion rate in patients with cardiac or renal impairment to avoid overload
  • Use aseptic technique to prevent contamination and infection
  • Verify compatibility with other IV medications before co‑administration
  • Observe for signs of allergic reaction during and after infusion

Avoid Interactions

Glucose/Sodium Chloride Fresenius Kabi can interact with other therapies, influencing safety and efficacy.

Avoid

  • Concurrent administration of high‑dose insulin without glucose monitoring, which may cause severe hypoglycemia
  • Use with hypertonic saline solutions that could exacerbate hypernatremia
  • Co‑infusion with medications that precipitate in high‑chloride environments (e.g., certain antibiotics)

Use with caution

  • Diuretics that may alter electrolyte balance
  • Beta‑blockers that can mask hypoglycemia symptoms
  • Corticosteroids that increase glucose levels
  • Renal replacement therapies that affect fluid and electrolyte removal

Frequently Asked Questions

It is designed to provide intravenous fluid, electrolytes (sodium and chloride), and glucose to restore volume, correct electrolyte imbalances, and supply energy.

It is used for dehydration, postoperative fluid replacement, hypoglycemia treatment, and as part of parenteral nutrition regimens.

The rate should be individualized based on the patient’s cardiac function, fluid status, and monitoring of vital signs to avoid fluid overload.

Compatibility should be checked for each medication; some drugs may precipitate or cause incompatibility when mixed with high‑chloride solutions.

Regular checks of blood glucose, serum electrolytes, fluid balance, and observation for infusion site reactions are recommended.

It may be used in pediatric care when dosing is adjusted appropriately; clinicians should follow pediatric dosing guidelines and monitor closely.

Signs can include severe hypernatremia (confusion, seizures), hyperchloremic acidosis (rapid breathing, fatigue), or fluid overload (shortness of breath, edema).

The glucose component provides rapid carbohydrate delivery, raising blood glucose levels quickly when administered intravenously.

Blood glucose should be closely monitored, and insulin dosing may need adjustment to prevent hyperglycemia.

Yes, but fluid and electrolyte inputs must be coordinated with the dialysis prescription to maintain balance.

Stop the infusion immediately, provide appropriate emergency care (e.g., antihistamines, epinephrine), and report the event.

Yes, it is classified as a prescription‑only (Rx) product and must be administered under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.